|
Collplant Biotechnologies Ltd (CLGN) |
|
Collplant Biotechnologies Ltd
CLGN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Collplant Biotechnologies Ltd growth rates, revenue grew
by 3565.22 % in IV. Quarter 2023 from the same quarter a year ago.
Ranking at No. 67
Medical Equipment & Supplies industry recorded
growth of revenues by 10.13 %
Collplant Biotechnologies Ltd net loss decreased from $-17 millions, to $-7 millions in IV. Quarter 2023,
• More on CLGN's Growth
|
|
Collplant Biotechnologies Ltd realized a net loss in trailing twelve months.
Collplant Biotechnologies Ltd realized cash reduction of $ -0.28 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 4.16.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.31.
• More on CLGN's Valuation
|
|
|
|
|
Collplant Biotechnologies Ltd realized net loss in trailing twelve months.
Collplant Biotechnologies Ltd realized cash outflow of $ -0.28per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 4.16.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.31.
Collplant Biotechnologies Ltd Price to Book Ratio is at 1.61 higher than Industry Avg. of -567.35, and higher than S&P 500 Avg. of 0.01
• More on CLGN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com